Harvard Apparatus Regenerative Technology EBITDA 2013-2024 | HRGN

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Harvard Apparatus Regenerative Technology ebitda from 2013 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Harvard Apparatus Regenerative Technology EBITDA 2013-2024 | HRGN

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Harvard Apparatus Regenerative Technology ebitda from 2013 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Related Stocks
Company Name	Market Cap
Elevance Health (ELV)	$99.6B
Cencora (COR)	$48.8B
DiDi Global (DIDIY)	$24.4B
ICON (ICLR)	$17.7B
Natera (NTRA)	$16.1B
Viatris (VTRS)	$15.7B
Avantor (AVTR)	$15.6B
Revvity (RVTY)	$15.1B
BioMerieux (BMXMF)	$13.1B
Solventum (SOLV)	$13B
CochLear (CHEOY)	$12.8B
Medpace Holdings (MEDP)	$11B
Charles River Laboratories (CRL)	$10.8B
Sonic Healthcare (SKHHY)	$8.8B
HealthEquity (HQY)	$8.5B
Doximity (DOCS)	$8.1B
Bausch + Lomb (BLCO)	$7.1B
Life Times (LTH)	$5.1B
Sotera Health (SHC)	$4.5B
Organon (OGN)	$4.2B
Surgery Partners (SGRY)	$3.9B
BrightSpring Health Services (BTSG)	$3.3B
PACS (PACS)	$3B
Alignment Healthcare (ALHC)	$2.6B
Concentras Parent (CON)	$2.6B
Ardent Health Partners (ARDT)	$2.5B
Premier (PINC)	$2.3B
GeneDx Holdings (WGS)	$2.1B
Ryman Healthcare (RYHTY)	$2B
GoodRx Holdings (GDRX)	$1.9B